Eve Health Group logo

Eve Health Group(ASX) EVE

Market CapA$5.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2004)-97%
5 Year-89%
1 Year-57%
1 Month-6%
A$0.02
+0.00%
+0.00Today
Eve Health Group last closing stock price
MetricPriceDate
Last closeAUD 0.022026-10-09
Eve Health Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%AUD 0.022026-10-01
1 month-6.25%AUD 0.022026-09-08
3 month-11.76%AUD 0.022026-07-10
Year to date-28.57%AUD 0.022025-12-30
1 year-57.14%AUD 0.042025-10-09
3 year-62.5%AUD 0.042023-10-10
5 year-89.29%AUD 0.142021-10-08
Since inception-96.61%AUD 0.442004-04-08

Eve Health Group Financials at a Glance

Market Cap

A$5.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$2.89M

Net Income (TTM)

-A$3.47M

EPS (TTM)

-A$0.01

P/E Ratio

-2.31

Dividend

A$0.00

Beta (Volatility)

0.10 (Low)

Price

A$0.02

Volume

642,818

Open

A$0.02

Previous Close

A$0.02

Daily Range

A$0.01 - A$0.02

52-Week Range

A$0.01 - A$0.04

Estimated Earnings Date

Feb 26, 2026

EVE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Eve Health Group

EVE Health Group Limited is an international provider of health, wellness, and nutritional products, based in Subiaco, Australia. The company specializes in organic tea tree oils, botanical oils, and medical nutrition solutions aimed at chronic and lifestyle ailments.

Products and Services
  • Organic tea tree oils and botanical oils
  • Medical nutrition solutions, including Gluco Smooth for diabetes management
  • Contract manufacturing services for various health products
Growth Outlook
  • Expansion into North America and Asia Pacific markets is underway
  • Focus on developing innovative health products to meet rising consumer demand
  • Strategic partnerships may enhance distribution capabilities and market reach
Financial Highlights
  • Recent quarterly revenue of AUD 520,227, showing a focus on recovery
  • Cash and cash equivalents increased to AUD 1,238,192, indicating liquidity
  • Current ratio of 4.28 suggests strong short-term financial health
EVE Health Group Limited operates in the packaged foods industry, with a focus on health and wellness products. The company has shown resilience despite recent financial challenges, as evidenced by its recent quarterly revenue figures. The increase in cash reserves indicates a solid liquidity position, which may support future growth initiatives. The current ratio of 4.28 reflects a strong ability to cover short-term liabilities, positioning the company favorably in the market. With ongoing efforts to expand into new regions and develop innovative products, EVE Health Group presents a compelling opportunity for potential investors interested in the health and wellness sector.
AI Generated • Sep 19, 2026

Industry

Food Products

CEO

Ben Rohr

Headquarters

Subiaco, WA 6008, AU

EVE Financials

Key Financial Metrics (TTM)

Gross Margin

-9.24%

Operating Margin

-164.81%

Net Income Margin

-163.97%

Return on Equity

-49.07%

Return on Capital

-48.15%

Return on Assets

-44.21%

Earnings Yield

-43.29%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$5.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

352.33M

Volume

642.82K

Avg. Volume

332.50K

Financials (TTM)

Gross Profit

A$717.52K

Operating Income

-A$3.03M

EBITDA

-A$3.22M

Operating Cash Flow

-A$3.36M

Capital Expenditure

-A$1.90K

Free Cash Flow

-A$3.36M

Cash & ST Invst.

A$1.24M

Total Debt

A$0.00

Eve Health Group Performance Analysis

Eve Health Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 2,330,65816.0%
20242024-06-30AUD 2,133,771-8.4%
20252025-06-30AUD 1,734,726-18.7%
20262026-06-30AUD 1,153,101-33.5%
Eve Health Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-310.8%
Q42025-06-30-27.6%
Q22025-12-31-13.1%
Q42026-06-30-17.8%
Eve Health Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.03-42.5%
20242024-06-30AUD -0.01-53.2%
20252025-06-30AUD -0.01-20.1%
20262026-06-30AUD -0.01-43.5%
Eve Health Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3150.0%
Q42025-06-30-5400.0%
Q22025-12-3141.8%
Q42026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$520.23K

-47.9%

Gross Profit

-A$148.74K

-248.4%

Gross Margin

-28.59%

N/A

Market Cap

A$5.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$1.76M

N/A

Employees

3

N/A

Net Income

-A$1.04M

-9.5%

EBITDA

-A$916.35K

-34.0%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$1.24M

+1066.3%

Total Debt

A$0.00

-100.0%

Accounts Receivable

A$63.78K

-19.0%

Inventory

A$110.55K

-21.9%

Long Term Debt

A$0.00

N/A

Short Term Debt

A$0.00

-100.0%

Return on Assets

-44.21%

N/A

Return on Invested Capital

-48.15%

N/A

Free Cash Flow

-A$833.64K

-59.2%

Operating Cash Flow

-A$833.64K

-59.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
WNX.AXWellnex Life Limited
A$0.08+0.00%
PFT.AXPure Foods Tasmania Limited
A$0.02+0.00%
ERG.AXEneco Refresh Limited
A$0.02+29.41%
8IH.AX8I Holdings Limited
A$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$22.18-9.81%
WFFWf
$12.29+499.51%
VZVerizon Communications
$41.65-8.75%
SPCXSpace Exploration Technologies
$162.57+1.25%

Questions About EVE

What is the current price of Eve Health Group?

Eve Health Group is trading at A$0.02 per share.

What is the 52-week range for Eve Health Group?

Over the past 52 weeks, Eve Health Group has traded between A$0.01 and A$0.04.

How much debt does Eve Health Group have?

As of the most recent reporting period, Eve Health Group reported total debt of A$0.00.

How much cash does Eve Health Group have on hand?

Eve Health Group reported A$1.24M in cash and cash equivalents in its most recent financial results.

What is Eve Health Group’s dividend yield?

Eve Health Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.